Table 4.
Study objectives | Provided data (n) | Provided data (%) |
---|---|---|
Objectives | 136 | 100 |
Effectiveness/efficacy | 97 | 71.3 |
Safety/adverse drug reaction | 96 | 70.6 |
Observation of application in everyday life (e.g. number of visits, dosage information) | 56 | 41.2 |
Influence of individual patients‘factors on therapy (e.g. age, concomitant therapy, concomitant disease) | 37 | 27.2 |
Quality of life | 20 | 14.7 |
Compliance | 18 | 13.2 |
Economics | 10 | 7.4 |
Others | 20 | 14.7 |
aMultiple answers were possible